テネシーにおけるダウン症候群の臨床試験
テネシー内の拠点で、ダウン症候群に関する8件の研究が参加者を募集しています。
テネシー内の都市
公式研究テキスト（英語）
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- East Tennessee Childrens Hospital, Knoxville
- The Children's Hospital at TriStar Centennial, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
被験者募集中第2相
1歳〜30歳 · 全性別 · 2026/09/01更新 · NCT04546399A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
- East Tennessee Childrens Hospital, Knoxville
- Saint Jude Children's Research Hospital, Memphis
- Vanderbilt University/Ingram Cancer Center, Nashville
被験者募集中観察研究
6歳〜39歳 · 全性別 · 2026/08/25更新 · NCT05702645A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
- Neurology Clinical, P.C., Cordova
被験者募集中第1/2相
35歳〜85歳 · 全性別 · 2026/07/10更新 · NCT05462106Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
- Vanderbilt University Medical Center Clinical Research Center, Nashville
被験者募集中第2相健康なボランティア歓迎
18歳〜55歳 · 全性別 · 2026/06/22更新 · NCT05231798Collaboration for Down Syndrome Progress (CDP)
- St. Jude Children's Research Hospital, Memphis
被験者募集中観察研究
全年齢 · 全性別 · 2026/06/04更新 · NCT07625579Drumming Lessons' Influence on Children With Down Syndrome
- Vanderbilt University, Nashville
被験者募集中
7歳〜15歳 · 全性別 · 2026/05/19更新 · NCT07156318Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Vanderbilt University Medical Center Center for Cognitive Medicine, Nashville
被験者募集中観察研究
25歳〜55歳 · 全性別 · 2026/05/18更新 · NCT04165109Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
- Woolfson Eye Institute, Chattanooga
- Woolfson Eye Institute, Johnson City
- Woolfson Eye Institute, Knoxville
被験者募集中第3相
8歳以上 · 全性別 · 2026/02/02更新 · NCT07135167ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。